Form 15-12G Aesthetic Medical Intern

August 11, 2026 6:08 AM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 15

 

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-39088

 

 

 

Aesthetic Medical International Holdings Group Limited

(Exact name of registrant as specified in its charter)

 

 

 

1122 Nanshan Boulevard

Nanshan District, Shenzhen

Guangdong Province, China 518052Telephone: +86 (755) 2665 0533

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Ordinary shares, par value US$0.001 per share

American depositary shares, each representing three ordinary shares

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  Rule 12g-4(a)(1)  
  Rule 12g-4(a)(2)  
  Rule 12h-3(b)(1)(i)  
  Rule 12h-3(b)(1)(ii)  
  Rule 15d-6  
  Rule 15d-22(b)  

 

Approximate number of holders of record as of the certification or notice date:  55    

 

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Aesthetic Medical International Holdings Group Limited has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

  Aesthetic Medical International Holdings Group Limited
Date: August 11, 2026  
  By: /s/ Guanhua Wu
  Name:  Guanhua Wu
  Title: Chief Financial Officer

  

 

 

 



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings